Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000215457-16-003982
Filing Date
2016-01-27
Accepted
2016-01-27 15:54:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 solazyme.inc.2015.txt SC 13G/A 11295
  Complete submission text file 0000215457-16-003982.txt   12996
Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Subject) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86676 | Film No.: 161364862
SIC: 2860 Industrial Organic Chemicals

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies